Particle
.news
Business
❯
Pharmaceuticals
❯
Drug Development
❯
Neuroscience
Cerevel Therapeutics
3 ARTICLES
last yr.
AbbVie Acquires Neuroscience Biotech Cerevel for $8.7 Billion